Synonyms: Example 3 [WO2010021918]
Compound class:
Synthetic organic
Comment: Veonetinib is the INN for a tyrosine kinase inhibitor from WHO proposed INN list 131 (August 2024). This is a racemic mixture of optical isomers. We show the structure without stereo-specificity to represent the racemate. The structure for veonetinib is claimed as Example 3 in patent WO2010021918 (Advenchen Laboratories) [1]. There is no information in this patent regarding the specific kinase(s) inhibited (just experimental evidence of antiproliferative activity against lung and colon cancer cell lines).
|
|
References |
1. Chen GPC. (2010)
Compounds as kinase inhibitors. Patent number: WO2010021918A1. Assignee: Advenchen Laboratories, Llc. Priority date: 13/08/2009. Publication date: 25/02/2010. |